State Street’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623M | Sell |
|
|||||
|
2025
Q1 | $688M | Buy |
|
|||||
|
2024
Q4 | $776M | Sell |
|
|||||
|
2024
Q3 | $802M | Sell |
|
|||||
|
2024
Q2 | $731M | Buy |
|
|||||
|
2024
Q1 | $445M | Sell |
|
|||||
|
2023
Q4 | $428M | Buy |
|
|||||
|
2023
Q3 | $424M | Buy |
|
|||||
|
2023
Q2 | $414M | Buy |
|
|||||
|
2023
Q1 | $402M | Buy |
|
|||||
|
2022
Q4 | $431M | Sell |
|
|||||
|
2022
Q3 | $334M | Buy |
|
|||||
|
2022
Q2 | $370M | Sell |
|
|||||
|
2022
Q1 | $292M | Buy |
|
|||||
|
2021
Q4 | $328M | Buy |
|
|||||
|
2021
Q3 | $270M | Buy |
|
|||||
|
2021
Q2 | $262M | Buy |
|
|||||
|
2021
Q1 | $231M | Sell |
|
|||||
|
2020
Q4 | $234M | Buy |
|
|||||
|
2020
Q3 | $152M | Sell |
|
|||||
|
2020
Q2 | $183M | Sell |
|
|||||
|
2020
Q1 | $182M | Buy |
|
|||||
|
2019
Q4 | $167M | Buy |
|
|||||
|
2019
Q3 | $150M | Buy |
|
|||||
|
2019
Q2 | $143M | Sell |
|
|||||
|
2019
Q1 | $261M | Buy |
|
|||||
|
2018
Q4 | $213M | Sell |
|
|||||
|
2018
Q3 | $265M | Buy |
|
|||||
|
2018
Q2 | $226M | Sell |
|
|||||
|
2018
Q1 | $235M | Buy |
|
|||||
|
2017
Q4 | $284M | Sell |
|
|||||
|
2017
Q3 | $245M | Buy |
|
|||||
|
2017
Q2 | $261M | Buy |
|
|||||
|
2017
Q1 | $270M | Buy |
|
|||||
|
2016
Q4 | $266M | Sell |
|
|||||
|
2016
Q3 | $232M | Sell |
|
|||||
|
2016
Q2 | $208M | Buy |
|
|||||
|
2016
Q1 | $206M | Buy |
|
|||||
|
2015
Q4 | $273M | Buy |
|
|||||
|
2015
Q3 | $211M | Buy |
|
|||||
|
2015
Q2 | $274M | Buy |
|
|||||
|
2015
Q1 | $237M | Buy |
|
|||||
|
2014
Q4 | $174M | Sell |
|
|||||
|
2014
Q3 | $175M | Sell |
|
|||||
|
2014
Q2 | $122M | Sell |
|
|||||
|
2014
Q1 | $134M | Sell |
|
|||||
|
2013
Q4 | $165M | Sell |
|
|||||
|
2013
Q3 | $126M | Buy |
|
|||||
|
2013
Q2 | $105M | Buy |
|